Joyce Meghan V. sold $445K of GH
Joyce Meghan V. sold 3,516 shares of Guardant Health, Inc. (GH) at $126.52 ($0.44M total) on 2026-06-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a datapoint on insider behavior but, by itself, does not change Guardant’s fundamentals or near-term catalyst calendar.
Market read
Traders may monitor for follow-on insider activity, but this specific transaction is unlikely to drive a major repricing absent additional company news.
What to watch
The filing does not indicate whether other insiders or large holders changed positions around the same time; broader ownership context could matter more than this single sale.
Background
SEC Form 4 reports insider transactions; Rule 10b5-1 plans are pre-arranged trading schedules intended to reduce timing-based inference.
Ticker impact
Guardant Health director Joyce Meghan V. sold 3,516 shares in an open-market transaction under a pre-arranged 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely modest and short-lived.
The filing is a routine insider transaction with explicit 10b5-1 pre-arrangement, reducing interpretive weight versus unscheduled selling.
Market effects
Minimal; this is company-specific insider activity without new operational/regulatory catalysts.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations, so the market reaction could be overdone.
Key entities
- issuerGuardant Health, Inc.
Subject of the Form 4 insider sale disclosed on June 4 for a June 3 open-market transaction.
- insiderJoyce Meghan V.
Director who sold 3,516 shares at ~$126.52/share under a 10b5-1 plan.
